India’s 'Thousand Talents' Moment And Models To Shift Gears In R&D

Might Korea, China Successes Provide Ideas?

Industry leaders including Sanofi's ex-CEO and the chiefs of Sun, Lupin, Glenmark, Dr Reddy’s and Cipla discuss how India could leapfrog its pharma R&D efforts. Could the South Korea model or a hybrid approach including bringing back top talent bolster the country’s efforts to emerge as a global innovation hot spot?

Talent
India Plans Push To Catalyze Biopharma Innovation • Source: Alamy

There’s a groundswell of biopharma innovation underway globally and CEOs at a recent conference discussed a range of approaches that India could draw from, including South Korea’s success in biotechnology or even the Italian wine industry model, to carve a niche for itself in the broader competitive R&D landscape.

Wooing top-notch talent back to India to aid in this effort was another key discussion point (see side box).

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia